SEC Form 4/A · accession 0000899243-18-002323
Seres Therapeutics, Inc. · MCRB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
John G. Aunins
Officer — See Remarks
Period of report
Dec 19, 2017
Accepted (ET)
Jan 30, 2018 · 8:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609809
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1,F2 | Dec 19, 2017 | M | 5,000 | — | A | 197,125 | D | |
| COMMON STOCKF2 | Dec 19, 2017 | S | 1,623 | $10.14 | D | 195,502 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- F2Due to a clerical error, the reporting person's original Form 4 filed on December 20, 2017 set forth an incorrect amount of common stock beneficially owned by the reporting person following the reported transaction. This Form 4/A corrects the error and presents the correct number of common stock beneficially owned by the reporting person following the reported transaction.
Remarks
Chief Technology Officer and EVP